# GE HealthCare Technologies Inc. – Consensus ‘buy’ rating and 29.4% Upside Potential

- Link: https://www.directorstalkinterviews.com/ge-healthcare-technologies-inc.consensus-buy-rating-and-29.4-upside-potential/4121126246
- Published: 2023-08-30T12:24:56+01:00
- Author: Charlotte Edwards

**GE HealthCare Technologies Inc.** with ticker code (GEHC) have now 9 market analysts
covering the stock. The analyst consensus now points to a rating of ‘buy’. The range
between the high target price and low target price is between 99 and 78 calculating
the average target price we see $89.67. Now with the previous closing price of $
69.31 this would indicate that there is a potential upside of 29.4%. The 50 day 
MA is $76.51 and the 200 day moving average is $74.56. The company has a market 
cap of 32.06B. The stock price for the company is currently is currently 70.48 USD

 The potential market cap would be $41,473,811,842 based on the market consensus.

The company has a dividend yield of 0.77%. Other points of data to note are a P/
E ratio of 19.52, revenue per share of 41.86 and a 5.77% return on assets.

GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics,
and digital solutions company. The Company develops, manufactures, and markets a
portfolio of products, services, and complementary digital solutions used in the
diagnosis, treatment, and monitoring of patients. The Company’s segments include
Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The 
Imaging segment includes scanning devices, clinical applications, service capabilities
and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment,
and monitoring of certain diseases. The Patient Care Solutions segment includes 
medical devices, services, consumable products, services, and digital solutions.
The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the
global radiology and nuclear medicine industry.

Share on: